Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels
- PMID: 31258105
- PMCID: PMC6712955
- DOI: 10.1017/S0033291719001454
Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels
Abstract
Background: Peripheral low-grade inflammation in depression is increasingly seen as a therapeutic target. We aimed to establish the prevalence of low-grade inflammation in depression, using different C-reactive protein (CRP) levels, through a systematic literature review and meta-analysis.
Methods: We searched the PubMed database from its inception to July 2018, and selected studies that assessed depression using a validated tool/scale, and allowed the calculation of the proportion of patients with low-grade inflammation (CRP >3 mg/L) or elevated CRP (>1 mg/L).
Results: After quality assessment, 37 studies comprising 13 541 depressed patients and 155 728 controls were included. Based on the meta-analysis of 30 studies, the prevalence of low-grade inflammation (CRP >3 mg/L) in depression was 27% (95% CI 21-34%); this prevalence was not associated with sample source (inpatient, outpatient or population-based), antidepressant treatment, participant age, BMI or ethnicity. Based on the meta-analysis of 17 studies of depression and matched healthy controls, the odds ratio for low-grade inflammation in depression was 1.46 (95% CI 1.22-1.75). The prevalence of elevated CRP (>1 mg/L) in depression was 58% (95% CI 47-69%), and the meta-analytic odds ratio for elevated CRP in depression compared with controls was 1.47 (95% CI 1.18-1.82).
Conclusions: About a quarter of patients with depression show evidence of low-grade inflammation, and over half of patients show mildly elevated CRP levels. There are significant differences in the prevalence of low-grade inflammation between patients and matched healthy controls. These findings suggest that inflammation could be relevant to a large number of patients with depression.
Keywords: C-reactive protein; CRP; depression; immunopsychiatry; inflammation; low-grade inflammation; meta-analysis; mood; prevalence; review.
Figures




References
-
- Almeida OP, Flicker L, Norman P, Hankey GJ, Vasikaran S, van Bockxmeer FM and Jamrozik K (2007) Association of cardiovascular risk factors and disease with depression in later life. The American Journal of Geriatric Psychiatry 15, 506–513. - PubMed
-
- Benedetti F, Lucca A, Brambilla F, Colombo C and Smeraldi E (2002) Interleukine-6 serum levels correlate with response to antidepressant sleep deprivation and sleep phase advance. Progress in Neuro-psychopharmacology and Biological Psychiatry 26, 1167–1170. - PubMed
-
- Benros ME, Waltoft BL, Nordentoft M, Østergaard SD, Eaton WW, Krogh J and Mortensen PB (2013) Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study. JAMA Psychiatry 70, 812–820. - PubMed
-
- Carvalho L, Torre J, Papadopoulos A, Poon L, Juruena M, Markopoulou K, Cleare A and Pariante C (2013) Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system. Journal of Affective Disorders 148, 136–140. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous